✦ LIBER ✦

High-dose cytosine arabinoside for acute nonlymphocytic leukemia

✍ Scribed by Dr. Guy Cantin; James K. Brennan

Publisher: John Wiley and Sons
Year: 1984
Tongue: English
Weight: 421 KB
Volume: 16
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.2830160108

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Low-dose cytosine arabinoside treatment

Low-dose cytosine arabinoside treatment for acute nonlymphocytic leukemia in elderly patients

✍ Herve Tilly; Sylvie Castaigne; Dominique Bordessoule; Francois Sigaux; Marie-thé 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 347 KB 👁 2 views

High dose cytosine arabinoside (HDARAC)

High dose cytosine arabinoside (HDARAC) in refractory acute leukemia

✍ Seth A. Rudnick; Edwin C. Cadman; Robert L. Capizzi; Roland T. Skeel; Joseph R. 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 415 KB 👁 2 views

Thirteen leukemic patients with disease refractory to conventional chemotherapy were treated with 1.0 to 7.5 g/m2 of Cytosine Arabinoside (Ara-C) over 29 drug cycles. Drug infusions were spaced at 12-hour intervals; a maximum of four doses was administered over 36 hours. After single dose tolerance

Treatment of “poor risk” acute nonlympho

Treatment of “poor risk” acute nonlymphocytic leukemia with continuously infused low-dose cytosine arabinoside

✍ Dr. Edward P. Balaban; John V. Cox; Nancy R. Schneider; Cheryl A. Harth; Barbara 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 431 KB 👁 1 views

Low-dose cytosine arabinoside in acute n

Low-dose cytosine arabinoside in acute non-lymphoblastic leukemia

✍ Lalit Kumar; V. Kochupillai; Harsch Dua 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 408 KB 👁 1 views

Epirubicin and cytosine arabinoside for

Epirubicin and cytosine arabinoside for the induction therapy of childhood acute nonlymphocytic leukemia

✍ Dr. Der-Cherng Liang; Chang-Jen Jiang 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 324 KB 👁 1 views

Mitoxantrone and high-dose cytosine arab

Mitoxantrone and high-dose cytosine arabinoside for the treatment of refractory acute lymphocytic leukemia

✍ Hagop M. Kantarjian; Ronald L. Walters; Michael J. Keating; Elihu H. Estey; SUSA 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 447 KB 👁 1 views

Twenty-five adult patients with refractory acute lymphocytic leukemia received salvage therapy with mitoxantrone 5 mg/m2 intravenously over 1 hour daily for 5 days and cytosine arabinoside 3 g/m2 intravenously over 2 hours every 12 hours for six doses. Overall, nine patients (36%) achieved complete